Cargando…
Impact of diabetes on surgery and radiotherapy for breast cancer
PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175479/ https://www.ncbi.nlm.nih.gov/pubmed/36997750 http://dx.doi.org/10.1007/s10549-023-06915-1 |
_version_ | 1785040220584935424 |
---|---|
author | Lawrenson, Ross Lao, Chunhuan Stanley, James Campbell, Ian Krebs, Jeremy Meredith, Ineke Koea, Jonathan Teng, Andrea Sika-Paotonu, Dianne Stairmand, Jeannine Gurney, Jason |
author_facet | Lawrenson, Ross Lao, Chunhuan Stanley, James Campbell, Ian Krebs, Jeremy Meredith, Ineke Koea, Jonathan Teng, Andrea Sika-Paotonu, Dianne Stairmand, Jeannine Gurney, Jason |
author_sort | Lawrenson, Ross |
collection | PubMed |
description | PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer Foundation New Zealand National Register, with diabetes status determined using New Zealand’s Virtual Diabetes Register. The cancer treatments examined included breast conserving surgery (BCS), mastectomy, breast reconstruction after mastectomy, and adjuvant radiotherapy after BCS. Logistic regression modelling was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (95% CI) of having cancer treatment and treatment delay (> 31 days) for patients with diabetes at the time of cancer diagnosis compared to patients without diabetes. RESULTS: We identified 25,557 women diagnosed with stage I–III breast cancer in 2005–2020, including 2906 (11.4%) with diabetes. After adjustment for other factors, there was no significant difference overall in risk of women with diabetes having no surgery (OR 1.12, 95% CI 0.94–1.33), although for patients with stage I disease not having surgery was more likely (OR 1.45, 95% CI 1.05–2.00) in the diabetes group. Patients with diabetes were more likely to have their surgery delayed (adjusted OR of 1.16, 95% CI 1.05–1.27) and less likely to have reconstruction after mastectomy compared to the non-diabetes group—adjusted OR 0.54 (95% CI 0.35–0.84) for stage I cancer, 0.50 (95% CI 0.34–0.75) for stage II and 0.48 (95% CI 0.24–1.00) for stage III cancer. CONCLUSIONS: Diabetes is associated with a lower likelihood of receiving surgery and a greater delay to surgery. Women with diabetes are also less likely to have breast reconstruction after mastectomy. These differences need to be taken in to account when considering factors that may impact on the outcomes of women with diabetes especially for Māori, Pacific and Asian women. |
format | Online Article Text |
id | pubmed-10175479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-101754792023-05-13 Impact of diabetes on surgery and radiotherapy for breast cancer Lawrenson, Ross Lao, Chunhuan Stanley, James Campbell, Ian Krebs, Jeremy Meredith, Ineke Koea, Jonathan Teng, Andrea Sika-Paotonu, Dianne Stairmand, Jeannine Gurney, Jason Breast Cancer Res Treat Epidemiology PURPOSES: This study aims to examine whether diabetes has an impact on the use of surgery and adjuvant radiotherapy in treating women with localised breast cancer. METHODS: Women diagnosed with stage I–III breast cancer between 2005 and 2020 were identified from Te Rēhita Mate Ūtaetae—Breast Cancer Foundation New Zealand National Register, with diabetes status determined using New Zealand’s Virtual Diabetes Register. The cancer treatments examined included breast conserving surgery (BCS), mastectomy, breast reconstruction after mastectomy, and adjuvant radiotherapy after BCS. Logistic regression modelling was used to estimate the adjusted odds ratio (OR) and 95% confidence interval (95% CI) of having cancer treatment and treatment delay (> 31 days) for patients with diabetes at the time of cancer diagnosis compared to patients without diabetes. RESULTS: We identified 25,557 women diagnosed with stage I–III breast cancer in 2005–2020, including 2906 (11.4%) with diabetes. After adjustment for other factors, there was no significant difference overall in risk of women with diabetes having no surgery (OR 1.12, 95% CI 0.94–1.33), although for patients with stage I disease not having surgery was more likely (OR 1.45, 95% CI 1.05–2.00) in the diabetes group. Patients with diabetes were more likely to have their surgery delayed (adjusted OR of 1.16, 95% CI 1.05–1.27) and less likely to have reconstruction after mastectomy compared to the non-diabetes group—adjusted OR 0.54 (95% CI 0.35–0.84) for stage I cancer, 0.50 (95% CI 0.34–0.75) for stage II and 0.48 (95% CI 0.24–1.00) for stage III cancer. CONCLUSIONS: Diabetes is associated with a lower likelihood of receiving surgery and a greater delay to surgery. Women with diabetes are also less likely to have breast reconstruction after mastectomy. These differences need to be taken in to account when considering factors that may impact on the outcomes of women with diabetes especially for Māori, Pacific and Asian women. Springer US 2023-03-30 2023 /pmc/articles/PMC10175479/ /pubmed/36997750 http://dx.doi.org/10.1007/s10549-023-06915-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Epidemiology Lawrenson, Ross Lao, Chunhuan Stanley, James Campbell, Ian Krebs, Jeremy Meredith, Ineke Koea, Jonathan Teng, Andrea Sika-Paotonu, Dianne Stairmand, Jeannine Gurney, Jason Impact of diabetes on surgery and radiotherapy for breast cancer |
title | Impact of diabetes on surgery and radiotherapy for breast cancer |
title_full | Impact of diabetes on surgery and radiotherapy for breast cancer |
title_fullStr | Impact of diabetes on surgery and radiotherapy for breast cancer |
title_full_unstemmed | Impact of diabetes on surgery and radiotherapy for breast cancer |
title_short | Impact of diabetes on surgery and radiotherapy for breast cancer |
title_sort | impact of diabetes on surgery and radiotherapy for breast cancer |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175479/ https://www.ncbi.nlm.nih.gov/pubmed/36997750 http://dx.doi.org/10.1007/s10549-023-06915-1 |
work_keys_str_mv | AT lawrensonross impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT laochunhuan impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT stanleyjames impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT campbellian impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT krebsjeremy impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT meredithineke impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT koeajonathan impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT tengandrea impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT sikapaotonudianne impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT stairmandjeannine impactofdiabetesonsurgeryandradiotherapyforbreastcancer AT gurneyjason impactofdiabetesonsurgeryandradiotherapyforbreastcancer |